Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CNTB compared with RNAC: revenue, margins and what each company keeps, and the suppliers and customers both name
CNTB
Connect Biopharma Holdings Ltd
Change
Mkt cap
Revenue
Revenue
RNAC
Cartesian Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CNTB
Connect Biopharma Holdings Ltd
vs
RNAC
Cartesian Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
CNTB: latest quarter is a loss; flow not drawable. RNAC: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CNTB, solid
RNAC, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CNTB
0
None
Shared
0
No disclosed counterparties: CNTB.
Only RNAC
8
BIIB
Biogen MA, Inc., or Biogen
supplier
—
National Institutes of Health
unlisted
supplier
—
Genovis AB (publ.)
unlisted
supplier
—
NCI
unlisted
supplier
4 more · RNAC chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
CNTB
Connect Biopharma Holdings Ltd
Change
0.76
· pre 0.78
· delayed
Mkt cap
$48.9M
Revenue
$3M
Q2 FY26
Revenue
—
RNAC
Cartesian Therapeutics, Inc.
Change
6.29
· pre 6.29
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$191.8M
Revenue
$78,000
Q1 FY26
Revenue
$3M
FY25
vs
Compare
Pre-market
Nov 2 '26
delayed
CNTB
Connect Biopharma Holdings Ltd
vs
RNAC
Cartesian Therapeutics, Inc.
0.76
pre 0.78
delayed
Price
6.29
pre 6.29
delayed
$48.9M
Mkt cap
$191.8M
Q2 FY26
$3M
Revenue
$78,000
Q1 FY26
—
Revenue
$3M
FY25
Change
Change
CNTB
0.76
vs
RNAC
6.29
Pre-market
Nov 2 '26
delayed